Avalotcagene ontaparvovec

DB16796InvestigationalGene Therapies

Avalotcagene ontaparvovec: Overview.

Code names
DTX-301 · KFB12DX3PF · SCAAV8OTC

Resolves to

Compound
UNII20E4R0BF12CAS2227000-30-6

What you can answer from here — as of September 25, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Avalotcagene ontaparvovec, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In